Cargando…

The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy

EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultures derived from a GBM with and without cells carr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yi-Hong, Chen, Yumay, Hu, Yuanjie, Yu, Liping, Tran, Katherine, Giedzinski, Erich, Ru, Ning, Gau, Alex, Pan, Francine, Qiao, Jiao, Atkin, Naomi, Ly, Khang Chi, Lee, Nathan, Siegel, Eric R., Linskey, Mark E., Wang, Ping, Limoli, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655244/
https://www.ncbi.nlm.nih.gov/pubmed/29113349
http://dx.doi.org/10.18632/oncotarget.20714
_version_ 1783273495548919808
author Zhou, Yi-Hong
Chen, Yumay
Hu, Yuanjie
Yu, Liping
Tran, Katherine
Giedzinski, Erich
Ru, Ning
Gau, Alex
Pan, Francine
Qiao, Jiao
Atkin, Naomi
Ly, Khang Chi
Lee, Nathan
Siegel, Eric R.
Linskey, Mark E.
Wang, Ping
Limoli, Charles
author_facet Zhou, Yi-Hong
Chen, Yumay
Hu, Yuanjie
Yu, Liping
Tran, Katherine
Giedzinski, Erich
Ru, Ning
Gau, Alex
Pan, Francine
Qiao, Jiao
Atkin, Naomi
Ly, Khang Chi
Lee, Nathan
Siegel, Eric R.
Linskey, Mark E.
Wang, Ping
Limoli, Charles
author_sort Zhou, Yi-Hong
collection PubMed
description EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultures derived from a GBM with and without cells carrying DM, for their differential molecular and metabolic profiles, in vivo growth patterns, and responses to irradiation (IR). Each cell line has a distinct molecular profile consistent with an invasive “go” (with DM) or angiogenic “grow” phenotype (without DM) demonstrated in vitro and in intracranial xenograft models. Cells with DM were relatively radio-resistant and used higher glycolytic respiration and lower oxidative phosphorylation in comparison to cells without them. The DM-containing cell was able to restore tumor heterogeneity by mis-segregation of the DM-chromosomes, giving rise to cell subpopulations without them. As a response to IR, DM-containing cells switched their respiration from glycolic metabolism to oxidative phosphorylation and shifted molecular profiles towards that of cells without DM. Irradiated cells with DM showed the capacity to alter their extracellular microenvironment to not only promote invasiveness of the surrounding cells, regardless of DM status, but also to create a pro-angiogenic tumor microenvironment. IR of cells without DM was found primarily to increase extracellular MMP2 activity. Overall, our data suggest that the DM-containing cells of GBM are responsible for tumor recurrence due to their high invasiveness and radio-resistance and the mis-segregation of their DM chromosomes, to give rise to fast-growing cells lacking DM chromosomes.
format Online
Article
Text
id pubmed-5655244
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56552442017-11-06 The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy Zhou, Yi-Hong Chen, Yumay Hu, Yuanjie Yu, Liping Tran, Katherine Giedzinski, Erich Ru, Ning Gau, Alex Pan, Francine Qiao, Jiao Atkin, Naomi Ly, Khang Chi Lee, Nathan Siegel, Eric R. Linskey, Mark E. Wang, Ping Limoli, Charles Oncotarget Research Paper EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultures derived from a GBM with and without cells carrying DM, for their differential molecular and metabolic profiles, in vivo growth patterns, and responses to irradiation (IR). Each cell line has a distinct molecular profile consistent with an invasive “go” (with DM) or angiogenic “grow” phenotype (without DM) demonstrated in vitro and in intracranial xenograft models. Cells with DM were relatively radio-resistant and used higher glycolytic respiration and lower oxidative phosphorylation in comparison to cells without them. The DM-containing cell was able to restore tumor heterogeneity by mis-segregation of the DM-chromosomes, giving rise to cell subpopulations without them. As a response to IR, DM-containing cells switched their respiration from glycolic metabolism to oxidative phosphorylation and shifted molecular profiles towards that of cells without DM. Irradiated cells with DM showed the capacity to alter their extracellular microenvironment to not only promote invasiveness of the surrounding cells, regardless of DM status, but also to create a pro-angiogenic tumor microenvironment. IR of cells without DM was found primarily to increase extracellular MMP2 activity. Overall, our data suggest that the DM-containing cells of GBM are responsible for tumor recurrence due to their high invasiveness and radio-resistance and the mis-segregation of their DM chromosomes, to give rise to fast-growing cells lacking DM chromosomes. Impact Journals LLC 2017-09-08 /pmc/articles/PMC5655244/ /pubmed/29113349 http://dx.doi.org/10.18632/oncotarget.20714 Text en Copyright: © 2017 Zhou et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Zhou, Yi-Hong
Chen, Yumay
Hu, Yuanjie
Yu, Liping
Tran, Katherine
Giedzinski, Erich
Ru, Ning
Gau, Alex
Pan, Francine
Qiao, Jiao
Atkin, Naomi
Ly, Khang Chi
Lee, Nathan
Siegel, Eric R.
Linskey, Mark E.
Wang, Ping
Limoli, Charles
The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
title The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
title_full The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
title_fullStr The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
title_full_unstemmed The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
title_short The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
title_sort role of egfr double minutes in modulating the response of malignant gliomas to radiotherapy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655244/
https://www.ncbi.nlm.nih.gov/pubmed/29113349
http://dx.doi.org/10.18632/oncotarget.20714
work_keys_str_mv AT zhouyihong theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT chenyumay theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT huyuanjie theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT yuliping theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT trankatherine theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT giedzinskierich theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT runing theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT gaualex theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT panfrancine theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT qiaojiao theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT atkinnaomi theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT lykhangchi theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT leenathan theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT siegelericr theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT linskeymarke theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT wangping theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT limolicharles theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT zhouyihong roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT chenyumay roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT huyuanjie roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT yuliping roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT trankatherine roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT giedzinskierich roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT runing roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT gaualex roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT panfrancine roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT qiaojiao roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT atkinnaomi roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT lykhangchi roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT leenathan roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT siegelericr roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT linskeymarke roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT wangping roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy
AT limolicharles roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy